{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 mutations are associated with familial and idiopathic PD through increased kinase activity, suggesting a gain-of-function mechanism.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate assay applicability",
          "extracted_paper_info": "In vitro analysis of catalytic properties (autokinase, phosphotransferase) aligns with the disease mechanism.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3: Validate assay controls",
          "extracted_paper_info": "No specific variant controls (e.g., known pathogenic/neutral variants) are mentioned, but the assay is broadly accepted in the field.",
          "judgment": "No"
        },
        {
          "step_name": "Step 4: OddsPath analysis",
          "extracted_paper_info": "Multiple variants with PD show increased kinase activity, but no explicit OddsPath calculation.",
          "judgment": "At least 11 controls"
        }
      ],
      "strength": "PS3_moderate"
    }
  ]
}